

소개
This book dives into the financial side of cancer treatment, focusing on immunotherapy. It analyzes costs of new treatments, comparing them to traditional methods.Chapter 1 gives an economic overview of cancer immunotherapy, including cost analyses, funding, and global impact. Chapter 2 explores checkpoint inhibitor pricing and financial aid models. Chapter 3 breaks down CAR T-cell therapy expenses, while Chapter 4 examines cancer vaccine development costs.



